This impairs the anti-AML leukocyte activities of cytotoxic lymphoid cells, and IL2 production is downregulated; additionally, the stress associated with these events leads AMLs to release HMGB1 (high-mobility group box 1), the protein that triggers the production of IL1β in healthy leukocytes [42]. This evidence concerns the gene IL2 and acute myeloid leukemia.